AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis
USA - NYSE:AMN - US0017441017 - Common Stock
17.175 USD
+0.32 (+1.93%)
Taking everything into account, AMN scores 4 out of 10 in our fundamental rating. AMN was compared to 100 industry peers in the Health Care Providers & Services industry. AMN has an average financial health and profitability rating. AMN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year AMN was profitable.
AMN had a positive operating cash flow in the past year.
Of the past 5 years AMN 4 years were profitable.
Each year in the past 5 years AMN had a positive operating cash flow.
1.2 Ratios
The Return On Assets of AMN (-12.88%) is worse than 79.00% of its industry peers.
The Return On Equity of AMN (-42.76%) is worse than 73.00% of its industry peers.
AMN has a Return On Invested Capital (2.08%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for AMN is above the industry average of 9.45%.
The 3 year average ROIC (13.14%) for AMN is well above the current ROIC(2.08%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.88% | ||
| ROE | -42.76% | ||
| ROIC | 2.08% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
1.3 Margins
AMN has a Operating Margin (1.65%) which is in line with its industry peers.
In the last couple of years the Operating Margin of AMN has declined.
AMN has a Gross Margin (29.37%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of AMN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 29.37% |
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
2. Health
2.1 Basic Checks
AMN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for AMN has been increased compared to 1 year ago.
Compared to 5 years ago, AMN has less shares outstanding
The debt/assets ratio for AMN has been reduced compared to a year ago.
2.2 Solvency
AMN has an Altman-Z score of 2.41. This is not the best score and indicates that AMN is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of AMN (2.41) is comparable to the rest of the industry.
AMN has a debt to FCF ratio of 3.80. This is a good value and a sign of high solvency as AMN would need 3.80 years to pay back of all of its debts.
AMN has a Debt to FCF ratio of 3.80. This is in the better half of the industry: AMN outperforms 73.00% of its industry peers.
AMN has a Debt/Equity ratio of 1.31. This is a high value indicating a heavy dependency on external financing.
AMN has a Debt to Equity ratio of 1.31. This is in the lower half of the industry: AMN underperforms 66.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.31 | ||
| Debt/FCF | 3.8 | ||
| Altman-Z | 2.41 |
ROIC/WACC0.26
WACC8.04%
2.3 Liquidity
AMN has a Current Ratio of 1.05. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.05, AMN is doing worse than 69.00% of the companies in the same industry.
AMN has a Quick Ratio of 1.05. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
AMN's Quick ratio of 1.05 is on the low side compared to the rest of the industry. AMN is outperformed by 66.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
The earnings per share for AMN have decreased strongly by -51.29% in the last year.
The Earnings Per Share has been growing slightly by 0.80% on average over the past years.
The Revenue for AMN has decreased by -11.42% in the past year. This is quite bad
Measured over the past years, AMN shows a small growth in Revenue. The Revenue has been growing by 6.07% on average per year.
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%
3.2 Future
The Earnings Per Share is expected to grow by 22.82% on average over the next years. This is a very strong growth
Based on estimates for the next years, AMN will show a small growth in Revenue. The Revenue will grow by 4.40% on average per year.
EPS Next Y-65.25%
EPS Next 2Y-43.85%
EPS Next 3Y-22.51%
EPS Next 5Y22.82%
Revenue Next Year-12.11%
Revenue Next 2Y-7.22%
Revenue Next 3Y-3.38%
Revenue Next 5Y4.4%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 9.09, the valuation of AMN can be described as very reasonable.
Based on the Price/Earnings ratio, AMN is valued cheaply inside the industry as 93.00% of the companies are valued more expensively.
AMN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.35.
AMN is valuated correctly with a Price/Forward Earnings ratio of 16.46.
AMN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AMN is cheaper than 72.00% of the companies in the same industry.
AMN is valuated cheaply when we compare the Price/Forward Earnings ratio to 33.72, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.09 | ||
| Fwd PE | 16.46 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AMN is valued cheaply inside the industry as 84.00% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, AMN is valued cheaper than 99.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.95 | ||
| EV/EBITDA | 7 |
4.3 Compensation for Growth
A cheap valuation may be justified as AMN's earnings are expected to decrease with -22.51% in the coming years.
PEG (NY)N/A
PEG (5Y)11.29
EPS Next 2Y-43.85%
EPS Next 3Y-22.51%
5. Dividend
5.1 Amount
AMN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:AMN (11/12/2025, 1:53:58 PM)
17.175
+0.32 (+1.93%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners105.31%
Inst Owner Change-0.81%
Ins Owners0.42%
Ins Owner Change0.71%
Market Cap658.15M
Revenue(TTM)2.72B
Net Income(TTM)-275.54M
Analysts69.23
Price Target20.98 (22.15%)
Short Float %6.17%
Short Ratio2.66
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.35%
Min EPS beat(2)53.64%
Max EPS beat(2)93.07%
EPS beat(4)4
Avg EPS beat(4)78.74%
Min EPS beat(4)52.24%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)44.14%
EPS beat(12)12
Avg EPS beat(12)33.45%
EPS beat(16)16
Avg EPS beat(16)27.33%
Revenue beat(2)1
Avg Revenue beat(2)0.79%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.64%
Revenue beat(4)3
Avg Revenue beat(4)2.05%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)4.75%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)7
Avg Revenue beat(12)1.02%
Revenue beat(16)11
Avg Revenue beat(16)1.39%
PT rev (1m)2.86%
PT rev (3m)-21.1%
EPS NQ rev (1m)-3.03%
EPS NQ rev (3m)-8.05%
EPS NY rev (1m)-0.32%
EPS NY rev (3m)0.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.93%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-1.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.09 | ||
| Fwd PE | 16.46 | ||
| P/S | 0.24 | ||
| P/FCF | 2.95 | ||
| P/OCF | 2.47 | ||
| P/B | 1.02 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7 |
EPS(TTM)1.89
EY11%
EPS(NY)1.04
Fwd EY6.08%
FCF(TTM)5.81
FCFY33.85%
OCF(TTM)6.96
OCFY40.52%
SpS70.9
BVpS16.82
TBVpS-10.79
PEG (NY)N/A
PEG (5Y)11.29
Graham Number26.74
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.88% | ||
| ROE | -42.76% | ||
| ROCE | 2.81% | ||
| ROIC | 2.08% | ||
| ROICexc | 2.16% | ||
| ROICexgc | 6.84% | ||
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 29.37% | ||
| FCFM | 8.2% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexgc growth 3Y-38.44%
ROICexgc growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score4
Asset Turnover1.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.31 | ||
| Debt/FCF | 3.8 | ||
| Debt/EBITDA | 4.12 | ||
| Cap/Depr | 27.3% | ||
| Cap/Sales | 1.62% | ||
| Interest Coverage | 0.95 | ||
| Cash Conversion | 129.62% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 | ||
| Altman-Z | 2.41 |
F-Score4
WACC8.04%
ROIC/WACC0.26
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
EPS Next Y-65.25%
EPS Next 2Y-43.85%
EPS Next 3Y-22.51%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%
Revenue Next Year-12.11%
Revenue Next 2Y-7.22%
Revenue Next 3Y-3.38%
Revenue Next 5Y4.4%
EBIT growth 1Y-66.5%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year92.53%
EBIT Next 3Y25.77%
EBIT Next 5YN/A
FCF growth 1Y-48.21%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-49.55%
OCF growth 3Y1.61%
OCF growth 5Y7.34%
AMN HEALTHCARE SERVICES INC / AMN FAQ
What is the fundamental rating for AMN stock?
ChartMill assigns a fundamental rating of 4 / 10 to AMN.
What is the valuation status of AMN HEALTHCARE SERVICES INC (AMN) stock?
ChartMill assigns a valuation rating of 6 / 10 to AMN HEALTHCARE SERVICES INC (AMN). This can be considered as Fairly Valued.
How profitable is AMN HEALTHCARE SERVICES INC (AMN) stock?
AMN HEALTHCARE SERVICES INC (AMN) has a profitability rating of 4 / 10.
How financially healthy is AMN HEALTHCARE SERVICES INC?
The financial health rating of AMN HEALTHCARE SERVICES INC (AMN) is 4 / 10.